Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction

By Lexis Chris   Wieringa Wouter   Hiemstra Bart   Deursen Vincent   Lipsic Erik   Harst Pim   Veldhuisen Dirk   Horst Iwan  

Cardiovascular Drugs and Therapy, Vol. 28, Iss. 2, 2014-04 ,pp. : 163-171

Springer Publishing Company

Access to resources Recommend Favorite

Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury

By Brunvand H.   Froyland L.   Hexeberg E.   Rynning S.E.   Berge R.K.   Grong K.  

European Journal of Pharmacology, Vol. 314, Iss. 1, 1996-10 ,pp. : 99-107

Elsevier

Access to resources Recommend Favorite

Omapatrilat Limits Infarct Size and Lowers the Threshold for Induction of Myocardial Preconditioning Through a Bradykinin Receptor-Mediated Mechanism

By Ebrahim Z.   Baxter G.F.   Yellon D.M.  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 2, 2004-03 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite

Dependency on Infarct Size Limits the Clinical Applicability of Non-Invasive Reperfusion Assessment by Biochemical Markers in Acute Myocardial Infarction

By  

Heart Drug, Vol. 1, Iss. 4, 2001-10 ,pp. : 197-206

Karger

Access to resources Recommend Favorite

Erythropoietin Just Before Reperfusion Reduces Both Lethal Arrhythmias and Infarct Size via the Phosphatidylinositol-3 Kinase-Dependent Pathway in Canine Hearts

By Hirata Akio   Minamino Tetsuo   Asanuma Hiroshi   Sanada Shoji   Fujita Masashi   Tsukamoto Osamu   Wakeno Masakatsu   Myoishi Masafumi   Okada Ken-ichiro   Koyama Hidekazu   Komamura Kazuo   Takashima Seiji   Shinozaki Yoshiro   Mori Hidezo   Tomoike Hitonobu   Hori Masatsugu   Kitakaze Masafumi  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 33-40

Springer Publishing Company

Access to resources Recommend Favorite